e-learning
resources
Munich 2006
Tuesday 05.09.2006
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary drug resistance against mycobacterium tuberculosis in a high burden country
M. Irfan, N. A. Rao, S. J. Hussain (Karachi, Pakistan)
Source:
Annual Congress 2006 - Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session:
Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Session type:
Poster Discussion
Number:
3445
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Irfan, N. A. Rao, S. J. Hussain (Karachi, Pakistan). Primary drug resistance against mycobacterium tuberculosis in a high burden country. Eur Respir J 2006; 28: Suppl. 50, 3445
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015
Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Primary drug resistance rates in pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003
Primary and acquired drug resistance in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005
Mycobacterium tuberculosis
drug resistance surveillance in Belarus
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
The problem of one drug resistance in tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006
Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Multidrug resistance of
M. tuberculosis
and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007
Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Primary drug resistant
Mycobacterium tuberculosis
in a tertiary TB center in Iran
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept